ArticleChemistry (Weinheim an der Bergstrasse, Germany)2026
Sustainable Synthesis of 4,7-Dihydro-4,7-ethano-2H-isoindoles-Key Building Blocks to Benzoporphyrins.
Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sustainable Synthesis of 4,7-Dihydro-4,7-ethano-2H-isoindoles-Key Building Blocks to Benzoporphyrins.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Benzoporphyrins, π extended porphyrin analogues, exhibit remarkable potential for optoelectronic and theragnostic applications, yet have remained largely confined to fundamental studies owing to the challenging synthesis of masked isoindole precursors. Here, we report a concise, scalable three-step synthesis of 4,7-dihydro-4,7-ethano-2H-isoindole, a key building block of the benzoporphyrin framework. Subsequent functionalization affords the corresponding α-ester derivative, enabling controlled access to diverse, lower-symmetry benzoporphyrin architectures. Compared with previous multistep strategies, this scalable route markedly reduces cost, waste generation, and synthetic complexity, representing the most practical synthetic approach to date. This advance enhances the synthetic accessibility of benzoporphyrins and paves the way for their broader implementation in molecular materials and biomedical applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.